Risk prognosis correlation of Insulin-like growth factor binding protein-3 and insulin-like growth factor-1 uterine fibroids: IGFBP-3 and IGF-1 in uterine fibroids
Scindeks Assistant Scindeks Assistant — A system for serious journals and those aspiring to become one
PDF

Abstract

Objective: To explore the relationships between the levels of serum insulin-like growth factor binding protein-3 (IGFBP-3) and insulin-like growth factor 1 (IGF-1) and immune factors as well as the prognosis of patients with uterine fibroids.

Methods: The study group consisted of 186 patients with uterine fibroids who had laparoscopic myomectomy between June 2023 and June 2024, whereas the control group consisted of 208 healthy women who had physical tests over the same time period. The patients in the study group were divided into a good prognosis group (84 patients) and a poor prognosis group (92 patients). The levels of GFBP-3, IGF-1 and immune factors in the study group and the control group, and their relationships with prognosis were analyzed.

Results: There were ten patients who left the study group and eight who left the control group. IGFBP-3 and IGF-1 in the study group were (303.18±42.39) mg/L and (1377.11±84.78) mg/L, which both outperformed those in the control contingent [(231.25±34.18) mg/L and (438.09±52.15) mg/L] (t=12.87, 19.63) P < 0.001). Whereas the levels of CD 3+, CD 4+, and CD 4+/CD 8+ were lower than those in the control group (t=7.92, 8.41, 5.21, P < 0.001). Both values were higher [(284.63±36.19) mg/L and (434.91±53.28) mg/L]. P < 0.001 (t=5.96, 64.19). While the numbers of CD 3+, CD 4+, and CD 4+/CD 8+ cells were lower than those in the good prognosis group (t=5.31, 7.03, 3.15). There was a positive correlation between CD 8+ status and IGFBP-3, history of uterine fibroids, number of fibroids, history of miscarriage, and duration of breastfeeding (r=0.593, 0.452, 0.446, 0.419, 0.422, respectively). IGF-1 was negatively correlated with CD 3+, CD 4+, and CD 4+/CD 8+ (r=-0.720, -0.751, and -0.712, respectively). IGF-1 was positively correlated with CD 8+ status, history of uterine fibroids, number of fibroids, history of miscarriage, and duration of breastfeeding (r=0.631, 0.503, 0.444, 0.501, 0.451). Number of fibroids, a history of miscarriage, and the length of breastfeeding were risk variables that impacted uterine fibroids patients' prognosis.

Conclusion: The levels of IGFBP-3, IGF-1 and CD-8+ in patients with uterine fibroids are relatively high. Moreover, IGFBP-3 and IGF-1 are related to immune factors and patient prognosis.

Keywords

Array
Array
Array
Array
DOI: 10.5937/jomb0-60550

References

The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Downloads

Download data is not yet available.